DSIP 10mg

Buy DSIP Peptide for sale in the UK from Archeus Karma Bio, a trusted supplier of high-quality research-grade peptides. DSIP (Delta Sleep-Inducing Peptide, also known as emideltide) is a nine amino acid neuropeptide first isolated from cerebral venous blood during induced slow wave sleep. It is one of the few peptides able to cross the blood brain barrier readily, and it has been studied for its role in delta wave sleep architecture, stress hormone modulation and pain threshold regulation. DSIP is a long-standing compound in sleep physiology, chronobiology and neuroendocrine research. Each batch from Archeus Karma Bio is lab-tested and verified for ≥99% purity, ensuring reliability and reproducibility in scientific research.

Key Features of DSIP Peptide for Sale

• Vial Size: 10mg per vial.
• Ultra-Pure Quality: Verified ≥99% purity by HPLC and Mass Spectrometry.
  Form: Lyophilized (freeze-dried) powder, intended strictly for laboratory research.
• Storage Instructions: Store between 2°C to 8°C (36 to 46°F), protected from light and moisture. After reconstitution, refrigerate and avoid multiple freeze-thaw cycles.
• Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE).
• Molecular Formula: C(35)H(48)N(10)O(15); molecular weight approximately 848.8 Da.
• CAS Number: 62568-57-4.
• Mechanism: Modulates delta wave sleep architecture and interacts with the hypothalamic-pituitary-adrenal axis and opioidergic signalling.

Scientific Overview: Mechanism & Research Applications

Mechanism of Action:

DSIP does not act on a single identified receptor. Instead it behaves as a neuromodulator, influencing several systems at once. Research points to interaction with GABAergic and opioidergic pathways, modulation of corticotropin-releasing hormone and ACTH output, and an effect on the timing and amplitude of delta wave activity during slow wave sleep.

Its small size and amphipathic character allow it to cross the blood brain barrier, which is unusual for a peptide of this class and is a large part of why it remains of interest in central nervous system research.

Key Research Findings Include:

• Sleep Architecture: Associated with increased delta wave activity and altered slow wave sleep patterns in experimental models.
• Stress Response: Investigated for normalising effects on the hypothalamic-pituitary-adrenal axis and corticosteroid output.
• Chronobiology: Studied for influence on circadian rhythm entrainment and sleep phase timing.
• Pain Threshold: Examined for antinociceptive activity via opioidergic mechanisms.
• Oxidative Stress: Explored for antioxidant and cellular protective activity in neural tissue models.